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Abstract 
Background: The Rhodococcus ruber strain Chol-4 genome contains at least three putative 3-ketosteroid Δ1-
dehydrogenase ORFs (kstD1, kstD2 and kstD3) that code for flavoenzymes involved in the steroid ring degradation. The 
aim of this work is the functional characterization of these enzymes prior to the developing of different biotechno-
logical applications.
Results: The three R. ruber KstD enzymes have different substrate profiles. KstD1 shows preference for 9OHAD and 
testosterone, followed by progesterone, deoxy corticosterone AD and, finally, 4-BNC, corticosterone and 19OHAD. 
KstD2 shows maximum preference for progesterone followed by 5α-Tes, DOC, AD testosterone, 4-BNC and lastly 
19OHAD, corticosterone and 9OHAD. KstD3 preference is for saturated steroid substrates (5α-Tes) followed by proges-
terone and DOC. A preliminary attempt to model the catalytic pocket of the KstD proteins revealed some structural 
differences probably related to their catalytic differences. The expression of kstD genes has been studied by RT-PCR 
and RT-qPCR. All the kstD genes are transcribed under all the conditions assayed, although an additional induction 
in cholesterol and AD could be observed for kstD1 and in cholesterol for kstD3. Co-transcription of some correlative 
genes could be stated. The transcription initiation signals have been searched, both in silico and in vivo. Putative 
promoters in the intergenic regions upstream the kstD1, kstD2 and kstD3 genes were identified and probed in an 
apramycin-promoter-test vector, leading to the functional evidence of those R. ruber kstD promoters.
Conclusions: At least three putative 3-ketosteroid Δ1-dehydrogenase ORFs (kstD1, kstD2 and kstD3) have been identi-
fied and functionally confirmed in R. ruber strain Chol-4. KstD1 and KstD2 display a wide range of substrate prefer-
ences regarding to well-known intermediaries of the cholesterol degradation pathway (9OHAD and AD) and other 
steroid compounds. KstD3 shows a narrower substrate range with a preference for saturated substrates. KstDs differ-
ences in their catalytic properties was somehow related to structural differences revealed by a preliminary structural 
modelling. Transcription of R. ruber kstD genes is driven from specific promoters. The three genes are constitutively 
transcribed, although an additional induction is observed in kstD1 and kstD3. These enzymes have a wide versatility 
and allow a fine tuning-up of the KstD cellular activity.
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Background
Rhodococci are aerobic Gram-positive soil bacteria 
belonging to the Actinomycetes group. They show a 
broad catabolic diversity over different substrates, from 
pollutants to many aromatic compounds, including ster-
oids and sterols [1–3]. Steroids are a source of contami-
nation of soil and waters and their presence has been 
detected even in drinking water, threatening many ways 
of life and public health [4–6]. Rhodococci can be use-
ful in this biodegradation field due to their metabolic 
versatility and steroids degradation capability. On the 
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other hand Rhodococcus spp. are potential biotechno-
logical tools [3, 7] as they can provide with key enzymes 
essential for certain reactions that yield industrial needed 
intermediaries such as 4-androstene-3,17-dione (AD) 
and 1,4-androstadiene-3,17-dione (ADD) [8].
But before exploiting all the advantages the different 
rhodococci offer, it is essential to know how these bacte-
ria degrade steroids and which enzymes are involved in 
this process.
Steroids are molecules with a carbon skeleton of 4 
fused rings (A to D) and a side chain up to 10 carbons. 
During the last years, the increasing number of stud-
ies concerning steroid degradation, and more concretely 
the degradation of cholesterol in bacteria, have clarified 
some of the catabolic steps (e.g. initiation of the ring deg-
radation by either a NAD+-dependent 3β-hydroxysteroid 
dehydrogenase or a cholesterol oxidase) although other 
steps still remain unclear (e.g. the processing of the C and 
D rings of the steroid structure or the relative order in 
which the different steps of the degradation of ring and 
chain occurs) [3, 9–12].
In the general scheme of steroid degradation, there are 
two key enzymes that initiate the opening of the steroid 
ring: the 3-ketosteroid-∆1-dehydrogenase [4-ene-3-oxos-
teroid: (acceptor)-1-ene-oxoreductase; EC 1.3.99.4)], also 
known as KstD and the 3-ketosteroid 9α-hydroxylase 
[Androsta-1,4-diene-3,17-dione; EC 1.14.13.142], also 
known as Ksh [13]. KstD is a flavoenzyme involved in 
the ∆1-dehydrogenation of the steroid molecule lead-
ing to the initiation of the breakdown of the steroid 
nucleus by introducing a double bond into the A-ring of 
3-ketosteroids [14, 15]. This flavoprotein converts 4-ene-
3-oxosteroids (e.g. AD) to 1,4-diene-3-oxosteroids (e.g. 
ADD) by trans-axial elimination of the C-1(α) and C-2(β) 
hydrogen atoms [16]. KstD homologs have been identi-
fied in 100 different bacterial species (78 actinobacteria, 
20 proteobacteria and 2 firmicutes) and at least in one 
fungus, Aspergillus fumigatus CICC 40167 [17, 18]. Most 
of these KstD-containing bacteria occur in soil, marine 
or river sediments and are also able to degrade polycy-
clic aromatic hydrocarbons [19]. Phylogenetic analysis 
leads to classify the KstD-like enzymes in at least 4 dif-
ferent groups, in which KstD1, KstD2, KstD3 of Rhodo-
coccus erythropolis SQ1 are representatives of three of 
them [20]. The crystal structure of the enzyme KstD1 of 
R. erythropolis SQ1 has been elucidated [21] confirming 
the presence of the two domains previously described, 
namely a N-terminal flavin adenine dinucleotide (FAD) 
binding motif and a substrate-binding domain [14, 20, 22, 
23].
The substrate range of different KstD proteins has been 
studied in R. erythropolis SQ1, being 3-ketosteroids with 
a saturated A-ring (e.g. 5α-androstane-3,17-dione and 
5α-testosterone) the preferred substrates for KstD3 and 
(9α-hydroxy-)4-androstene-3,17-dione the favourite one 
for both KstD1 and KstD2 [20]. It should be mentioned 
that, apart from their role in steroids degradation, KstD 
proteins could have specific roles depending of their ori-
gin; for instance, the KstD of A. fumigatus CICC 40167 is 
involved in fusidane antibiotic biosynthesis [17].
We have previously reported the occurrence of three 
KstD enzymes in R. ruber (NCBI::AFH57399 for KstD1; 
NCBI::AFH57395 for KstD2 and NCBI::ACS73883 for 
KstD3) [24]. Growth experiments with single, double or 
triple kstD mutants proved that KstD2 is a key enzyme in 
the transformation of both AD to ADD and 9α-hydroxy-
4-androstene-3,17-dione (9OHAD) to 9α-hydroxy-1,4-
androstadiene-3,17-dione (9OHADD) while both KstD2 
and KstD3 are involved in the cholesterol catabolism in 
R. ruber. On the other hand, the role of KstD1 on the 
steroids catabolism remains unclear as kstD1 mutation 
did not affect growing of this strain in steroids [24]. In 
this study, we cloned the three kstD ORFs and heterolo-
gously expressed them in R. erythropolis CECT3014, in 
order to initiate the biochemical characterization of the 
encoded enzymes, as the basis for further studies on 
their applications. The results revealed that KstD3 uses 
more actively substrates with a saturated ring in contrast 
to KstD1 and KstD2. Additionally, we located and func-
tionally defined the promoters of the three kstD ORFS in 
order to provide a basis for future research on the regula-
tion of these genes.
Methods
Bacterial strains, plasmids and growth conditions
Rhodococcus ruber strain Chol-4 (CECT 7469; DSM 
45280) was isolated from a sewage sludge sample [25]. 
This strain was routinely grown in Luria-Bertani (LB) or 
minimal medium (M457 of the DSMZ, Braunschweig, 
Germany) containing the desired carbon and energy 
source under aerobic conditions at 30  °C in a rotary 
shaker (250  rpm) for 1–3  days. For the steroids growth 
experiments, a LB pre-grown culture was washed two 
times with minimal medium prior to inoculation. Choles-
terol or AD (Sigma), were added directly to the minimal 
medium culture for growing and/or induction at 0.6 and 
0.44 g/L, respectively. Escherichia coli strains were grown 
in LB broth at 37 °C, 250 rpm. For the promoter growth 
experiments, cells were plated in minimal medium M457 
plates containing the desired carbon source and incu-
bated at 30 °C for 3 days. Cholesterol and AD were pre-
viously dissolved in methyl-β-cyclodextrin (CD) [26] and 
prepared as described [27]. Plasmids and bacterial strains 
used are listed in Additional file 1. Competent cells of E. 
coli DH5αF’ and BL21 (DE3) were prepared and trans-
formed by standard protocols [28].
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Cloning of kstD1, kstD2 and kstD3 of R. ruber strain Chol‑4 
and heterologous expression in Rhodococcus erythropolis 
CECT3014 cells
Chromosomal DNA extraction of R. ruber grown in a 
LB agar plate was performed using the hexadecyltri-
methylammonium bromide (CTAB) procedure [29] with 
the following modifications. Bacterial cells were col-
lected, suspended in 400 µL Tris–EDTA buffer (10 mM 
Tris/HCl, pH 8.1  mM EDTA) and incubated at 80  °C 
for 20 min. Afterwards, a lysozyme treatment (50 µL of 
10 mg/mL stock) was carried out at 37 °C for 1–12 h, and 
then 75 µL of SDS containing proteinase K (70 µL SDS 
10% wt/vol plus 5 µL proteinase K 10 mg/mL) was added 
and incubated for 10 min at 65 °C. Proteins were precipi-
tated with 100 µL of 5 M NaOH and 100 µL CTAB (0.1 g/
mL suspended in 0.7 M NaOH) for 10 min at 65 °C. DNA 
was purified by extraction with chloroform-isoamyl 
alcohol (24:1) and phenol-chloroform-isoamyl alcohol 
(25:24:1) and precipitated with 0.6 vol of isopropanol at 
room temperature for 30 min. After centrifugation, DNA 
was washed with 70% ethanol and suspended in distilled 
water.
The kstD ORFs were previously identified using the 
Bioedit program [25] and they were PCR amplified, 
from start to stop codon, using primers from Additional 
file  2. PCR was performed under standard conditions 
using High Fidelity PCR Enzyme Mix (Fermentas) with 
a specific high GC buffer (Roche) at 30 cycles of 1  min 
at 95 °C, 1 min at the desired Tm and 0.5–3 min at 72 °C 
(unless stated otherwise).
NdeI-BamHI (kstD3), NdeI-BglII (kstD2 and kstD1) 
restricted PCR products were first cloned into pGEM-T 
Easy Vector (Promega) and then moved to the shuttle 
vector pTip-QC1 [30]. Expression plasmids either with 
or without a kstD ORF were used to electroporate Rho-
dococcus erythropolis CECT3014. Selection was made 
in LB with 34  µg/mL Cm. Cultures of R. erythropolis 
harbouring expression plasmids (pTip-KsTD1, pTip-
KstD2, pTip-KstD3 or pTip-QC1) were grown (30  °C, 
200  rpm) in 50  mL LB broth supplemented with Cm 
until an OD600nm of 0.6–0.8. After that, expression was 
induced by adding 1 µg/mL thiostrepton (Sigma) to the 
culture. Cells were kept growing for 24 h more and they 
were collected at 5000 rpm for 10 min, washed twice in 
50 mM phosphate buffer pH 7.0, concentrated to 5 mL 
and sonicated. The resulting cell extracts were used for 
analysis of KstD activity with a range of steroid sub-
strates. Total protein content was measured by Brad-
ford assay [31]. Samples were analysed by PAGE-SDS in 
12.5% wt/vol gels and using 10  µg of total protein per 
lane.
KstD enzymatic assay
The kinetic of the enzymatic extracts was determined as 
previously stated [20, 32]. The cell-free extracts were incu-
bated with AD (Sigma), 9OHAD (Organon Biosciences), 
17β-hydroxy-5α-androstan-3-one or 5α-Tes, DOC (deox-
ycorticosterone), testosterone, corticosterone, 19OHAD, 
progesterone (Sigma), 4-BNC (4-pregnen-3-one-20β-
carboxylic acid) (Steraloids), 5β-androstane-3,17-dione 
(Steraloids), 4-cholestene-3-one (Sigma) or 5α-cholestan-
3-one (Acros Organics). Structures of steroids used in 
this study are shown in Additional file 3. Enzyme activi-
ties were measured spectrophotometrically at 30 °C using 
2,6-dichlorophenol-indophenol (DCPIP, Sigma) as an 
artificial electron acceptor. The reaction mixture (1  mL) 
consisted of 50 mM Tris (pH 7), 80 μM DCPIP, cell-free 
extract and 200  μM steroid in ethanol (methanol in the 
case of 5α-cholestane-3-one). Four replicates were ana-
lysed. Activities are expressed as mean values  ±  SD in 
units per milligram of protein; one unit is defined as the 
amount of enzyme which causes the reduction of 1 µmol 
of DCPIP/min (ε600 =  21  mM−1  cm−1) after taking into 
account the value of the activity of control (cells harbour-
ing the empty pTip-QC1 vector) for a certain steroid. 
Total protein concentration (mg/mL) was measured by 
Bradford assay [31]. The kinetics of the KstD enzymes 
were determined by incubating the cell-free extracts with 
varying concentrations of steroid substrates. The kinet-
ics parameters were analysed by nonlinear regression 
curve fitting of the data to the Michaelis- Menten equa-
tion using Hyper32 1.0 software (Informer Technologies, 
http://hyper32.software.informer.com/).
Expression analysis by RT‑PCR and RT‑qPCR
RNA samples for RT-PCR experiments were obtained 
from mid-log exponential phase cultures (OD600nm 0.7–
0.8). Total RNA was prepared with the RNeasy Mini Kit 
(Qiagen) following the manufacturer’s indications with 
the following modification: 50  mg of acid-washed glass 
beads (150 μm diameter) were added in the first step and 
each sample was shaken at maximum speed in a Bullet 
Blender for 5 min. The cell debris was removed by cen-
trifugation. The supernatant was subjected to the RNe-
asy Mini Kit (Qiagen) protocol. The total RNA obtained 
(0.5–1  μg) was treated once with 5 U of Turbo DNase 
RNase-Free (Ambion) in a 700  μL volume for 2  h at 
37 °C. RNA samples were extracted with 1 volume of acid 
phenol (Sigma), vigorously shaken and incubated at room 
temperature for 15 min. After 15 min centrifugation, the 
upper phase was precipitated by addition of 0.12 volumes 
of 5 M NH4Ac, 0.02 volumes of glycogen (5 mg/mL) and 
1 volume of isopropanol, washed twice in 70% ethanol 
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and dissolved in water. Samples were treated with DNase 
until no DNA was detected by PCR to avoid DNA con-
tamination. The RNA concentration was then evaluated 
using a NanoDrop Spectrophotometer ND-1000.
For the RT-PCR the cDNA was synthesized using Super-
Scrip III Reverse Transcriptase (Invitrogen) following the 
manufacturer’s indications. cDNA was used as template 
(25  ng) for PCR reactions (20 μL final volume). Controls 
without reverse transcriptase (RT-) were used to detect any 
contamination of undigested DNA in the RNA prepara-
tions. PCR products were analysed in 0.8% agarose gels.
To quantify the expression of the three KstD genes, a 
RT-qPCR analysis was performed using RNA from wild-
type strains cultured in M457 minimal medium contain-
ing the desired carbon and energy source (2 g/L sodium 
acetate, 0.44  g/L AD or 0.6  g/L cholesterol). The RNA 
quality was assessed by using Bioanalyzer 2100 (Agilent). 
cDNA was synthetized using 1 μg of RNA with the high 
capacity RNA to cDNA Kit (Applied Biosystems). The 
RT-qPCR analysis of cDNA was performed on Applied 
Biosystems QuantStudio 12K Flex Real-Time PCR Sys-
tems. The reaction conditions were 10 min at 95  °C fol-
lowed by 40 cycles of 15  s at 95  °C and 1  min at 60  °C 
for extension. The temperature of the melting curve 
was from 60 to 95  °C. The FAD-binding dehydrogenase 
D092_14375 gene was used as an internal control to nor-
malize messenger RNA levels. All reactions were per-
formed in triplicate. The RT-qPCR experiment and the 
analysis of the relative fold difference of each gene using 
the 2−∆∆Ct algorithm was performed in the Genomic unit 
of Universidad Complutense de Madrid.
The sodium acetate grown culture was used as the 
reference medium. Therefore, the relative expression 
indicates how many times the expression level of a cer-
tain gene is detected respect to the levels detected when 
growing on sodium acetate.
In silico analyses
DNASTAR (Lasergene) programs were used to ana-
lyse sequences and to design primers. The R. ruber 
strain Chol-4 genomic DNA has been previously 
sequenced [33]. BioEdit program was used to per-
form local-blast alignments within the genome data 
(NCIB::ANGC01000000). Putative signal peptides were 
predicted by SignalP 4.1 server using a model trained on 
Gram-positive bacteria [34]. Sigma 70 putative promot-
ers predictions were performed using the BPROM server, 
a bacterial sigma 70 promoter recognition program with 
about 80% accuracy and specificity [35], the Neural Net-
work Promoter Prediction (NNPP) based on prokaryotes 
[36] in all cases with a score value of ≥80%, or the web-
server PePPER for prediction of prokaryote promoter 
elements and regulons [37].
For the protein modelling we employed different soft-
ware. I-Tasser (http://zhanglab.ccmb.med.umich.edu/I-
TASSER) was used for an approach to protein structure 
and function prediction [38] and PredictProtein (www.
predictprotein.org/home) was used for the second-
ary structure, solvent accessibility and transmembrane 
helix prediction [39]. COBALT was used as a multiple 
sequence alignment tool to find similarities among the 
catalytic residues (www.ncbi.nlm.nih.gov/tools/cobalt/
re_cobalt.cgi) [40] and PyMOL (www.pymol.org/) as 
a molecular visualization system (PyMOL Molecular 
Graphics System, Version 0.99, Schrödinger).
Promoter cloning and characterization
The NheI-PciI 0.4  Kb multiple cloning site (mcs) from 
pSEVA351 [41, 42] was cloned into pNV119 vector [43], 
from now on named as pNVS (Additional file 4).
The putative kstD promoter sequences were amplified 
by PCR, from the end of the upstream flanking gene to 
the end of the first six amino acid codifying sequence. 
The XbaI, PstI-flanked kstD promoter regions (kstD1p, 
kstD2p and kstD3p) and the KpnI, PstI-flanked kstD3bp 
minimal promoter were cloned into pNVS. The resulting 
vectors were designated pNVSP1, pNVSP2, pNVSP3 and 
pNVSP3b, respectively.
Apramycin resistance gene (Amr) was amplified by 
PCR from plasmid pIJ773 [44], from start to stop codon. 
The NruI/HindII digested Amr fragment was cloned in 
each one of the previous kstD constructions. The result-
ing plasmids were checked by sequencing (Secugen) 
and named pNVSP1-A, pNVSP2-A, pNVSP3-A and 
pNVSP3b-A, respectively.
All the primers used are listed in Additional file 2. PCR 
was performed under standard conditions using High 
Fidelity PCR (Roche) with glycerol 5% and a basic pro-
gram unless stated otherwise.
As a control, a plasmid without any promoter but car-
rying the Amr gene (pNVSA) was made by digesting 
pNVSP1-A with NruI-XbaI; the resulting 4.2  Kb frag-
ment was cut from a 1% agarose gel and purified with 
GENECLEAN Turbo Kit. Blunt ends suitable for liga-
tion with T4 DNA ligase (Takara) were generated using 
the End repair kit (DNA terminator, Lucigen). The final 
ligated product was used to transform E. coli DH5αF′. 
Deletion was checked by sequencing (Secugen).
Every one of the plasmid set was introduced in R. 
ruber strain Chol-4 by electroporation (200 or 400 µL 
cells with 1 µg DNA at 400 Ω, 25 mA, 2.5 µF; 10–11 ms), 
the resulting cells were suspended in 800 µL of LB and 
kept for 6 min at 46  °C, and then for 5 h at 30  °C with-
out shaking. Finally, they were plated on LB Agar with 
200  μg/mL kanamycin and kept at 30  °C. To verify the 
presence of plasmids, two colonies of each plate were 
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picked and grown in 3 mL of LB-200 μg/mL kanamycin. 
Plasmid were extracted using the method described in 
Hopwood et al. [45] and used to transform E. coli strain 
DH5αF’ [28]. Plasmids obtained from E. coli colonies 
grown at 37 °C in 50 μg/mL kanamycin were verified by 
sequencing (Secugen). Finally, those colonies of R. ruber 
strain Chol-4 harbouring the right recombinant plasmids 
were picked and grown in agar minimal media at 30  °C 
with different carbon source with or without apramycin 
(300 μg/mL) or kanamycin (200 μg/mL).
To define the transcriptional start sites (TSS) of kstD 
promoters, a transcription start point protocol (ARF-
TSS) [46] was used on R. ruber cells with the following 
modifications.
RNA from R. ruber cells growing in different carbons 
sources cultures was isolated. The culture media were: LB 
for kstD1 TSS, minimal medium supplemented with AD 
for kstD2 TSS and minimal medium supplemented with 
cholesterol for kstD3 TSS. Total RNA was isolated as 
described previously [47]. It was qualified by electropho-
resis and quantified by Nanodrop 1000 (NanoDrop Tech-
nologies). 20 µg of RNA were reverse transcribed with a 
gene specific phosphorylated 5′-end primer (R1 for each 
kstD) using SuperScrip III Reverse Transcriptase from 
Invitrogen. As a result, cDNA fragments with the TSS 
as 3′-end were generated and purified. After removing of 
RNA with 0.5 µg/µL RNase A (37 °C for 30 min), cDNA 
was purified using the GENECLEAN turbo Kit (MPI) 
and final products were treated with T4 RNA ligase from 
Fermentas (10U, 37  °C for 30 min). This T4 RNA ligase 
catalyses the ATP-dependent intra- and intermolecular 
formation of phosphodiester bonds between 5′-phos-
phate and 3′-hydroxyl termini of oligonucleotides, sin-
gle-stranded RNA and DNA. It was used in this study 
to circularize the cDNA. The circularized cDNAs were 
then used as template for PCR amplification with Expand 
High Fidelity (Roche) using R2 and F3 primers specific 
for each kstD ORF. PCR products were purified using the 
GENECLEAN turbo Kit and sequenced (Secugen). The 
nucleotide upstream the 5′-end of the R1 primer is the 
transcription initiation site.
Results and discussion
As we have published earlier, the R. ruber strain Chol-4 
genome contains three putative 3-ketosteroid Δ1-
dehydrogenase ORFs (kstD1, kstD2 and kstD3) that code 
for flavoenzymes involved in the steroid ring degradation 
[24]. Growth experiments with kstD mutants proved that 
KstD2 is the main enzyme involved in the transforma-
tion of AD to ADD. R. ruber kstD2 mutants accumulate 
9OHAD from AD due to the action of a 3-ketosteroid-
9α-hydroxylase (KshAB). On the other hand, only the 
strains lacking both KstD2 and KstD3 were unable to 
grow in minimal medium with cholesterol as the only car-
bon source. In order to know more about these R. ruber 
enzymes, we have performed transcriptional studies and 
followed their heterologous expression in R. erythropolis 
to detect their activities on a set of different substrates.
In silico analyses of kstD promoter regions of R. ruber strain 
Chol‑4
A scheme of the three R. ruber kstD ORFs and their 
genomic surroundings is depicted in Fig. 1 showing also 
the in silico predicted pP1, pP2, pP3, pP4 and pP5 pro-
moters. The available programs (see “Methods”) yielded 
no putative promoter region just upstream either kstD1 
or kstD2 ORFs, although it should be noted here that 
promoter prediction programs are not specific for Gram-
positive species.
However, these programs detected putative promot-
ers (pP1, pP2 and pP4) upstream the cyp450 gene, lying 
in the intergenic region of the fadA5-hyp and cyp450-
kstD1-MFSt opposite clusters. Flanking the pP1 putative 
promoter there are two palindromic sequences (TagAA-
CagGTTgtc and TagAACgtGTTccA) (Fig. 2), one of them 
rather similar and the second one identical to the consen-
sus binding region reported for the KstR regulatory pro-
tein of Mycobacterium (TnnAACnnGTTnnA) [48]. KstR 
and KstR2, two TetR family repressor regulators, have 
been found to control most of the steroid pathways in 
actinobacteria [48–50]. KstR is a highly conserved TetR 
Fig. 1 Schematic representation of R. ruber strain Chol-4 DNA kstD 
regions. Putative promoters (pP) predicted using the BPROM (pP1: 
TTCCTT−35..TGCTTGAAT−10), PePPER (pP2: TTGAATGCTTTTAGAACGT 
GTTCCACATCgcgaC+1 and pP3: TGGACTCACCGCGCCATCATTCTAT 
AACgtgtT+1) or NNPP programs (pP4: GGTTGTCGTGGCGGACAAGGT
GTGGTCCGAATGATCGGGAC+1TTGGCGATT and pP5: GAAGGGATGGA
CTCACCGCGCCATCATTC+1TATAACGTG) are shown in grey flags. TSS 
derived promoters (pKstD1, pKstD2) appear in black flags. Positive 
(solid line) and negative (dotted line) results of the amplification of 
co-transcribed products are depicted. hyp hypothetical protein, fadA5 
acetyl-CoA acyltransferase, cyp450 cytochrome P450, pep hypotheti-
cal peptide, MFSt major facilitator superfamily transporter, kshA 
3-ketosteroid 9α-hydroxylase, ox oxidoreductase, Tn transposase, hsaF 
4-hydroxy-2-oxovalerate aldolase, hsaG acetaldehyde dehydrogenase, 
hsaE 2-hydroxypenta-2,4-dienoate hydratase, hsd4B 2-enoyl acyl-CoA 
hydratase, choG cholesterol oxidase
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Fig. 2 Sequence of regions upstream kstD ORFs. Solid arrows represent the orientation of the different ORFs from the initiation to the final codon. 
Sequences similar to Mycobacterium KstR binding sites (TnnAACnnGTTnnA) are within a square. Palindromic sequences appear in bold characters 
and dotted underlined. Shine Dalgarno (SD) sequences are in italics and underlined. The −10, −35 boxes are marked in grey. The in silico transcription 
initiation point of the putative pP1, pP2, pP3 and pP4 promoters are in italics and marked as pP(+1). The transcription start sites of kstD1 and kstD2 
ORF obtained by the ARF-TSS method are shown in bold italics and marked as pKstD(+1). The TCCG repeats and the Sal box upstream kstD2 are dou-
ble underlined. Promoter signals similar to others described (e.g. M. tuberculosis) [55] appear in bigger size. Primer CH488 indicating the beginning of 
the minimum kstD3 promoter is also shown
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family repressor that regulates the transcription of genes 
related to the upper and central pathway of cholesterol 
catabolism, namely the membrane transport of choles-
terol, the degradation of the steroid side chain and the 
opening of the A and B rings [12, 48]. Upon binding to a 
3-oxo-4-cholestenoic acid or to a CoA thioester choles-
terol metabolite, KstR releases the DNA and allows tran-
scription to begin [51, 52]. The KstR binding motif has 
been proved to be conserved within actinobacteria [48, 
53].
The possible co-transcription of the cyp450-kstD1-
MSFt ORF cluster to a polycistronic mRNA would come 
into contradiction with the transcription of a non-yet 
described short putative ORF (pep, Fig.  1) located in 
opposite sense in the 425  bp cyp450-kstD1 intergenic 
region. This short ORF might code for a 35 amino acid 
peptide which shows a 98% amino acid identity with part 
of the hypothetical 78 aa protein RHRU231_750039 (R. 
ruber, 78 aa). Therefore, kstD1 might be independently 
transcribed while pP1/pP2/pP4 putative promoters 
might be only involved in cyp450 transcription. Moreo-
ver, a putative ribosome binding site (GAAAGG) was 
found 9 bp upstream the kstD1 initiation codon (Fig. 2) 
that is identical to the proposed one for sigA of R. ruber 
TH [54].
In the case of the kstD2 ORF, none of the online pro-
grams recognized a promoter consensus, although this 
region contains some quasi-palindromic sequences and a 
Shine-Dalgarno-like motif (AGGAGC) (Fig. 2).
There are two putative promoters for the kstD3 ORF 
(pP3 and pP5, see Figs. 1 and 2) that lie in the intergenic 
region between hsaE and kstD3 ORFs. The putative pro-
moter pP3 contains the sequence TATAAC similar to 
the −10 consensus motif described for M. smegmatis 
promoters (T100%A93%T50%A57%A43%T71%) [55], and a −35 
region (TGGACT) that resembles the E. coli promoter 
consensus motif TTGACA. In this region, there are 
also a tandem of two putative KstR binding sequences 
around this promoter (TgcAACctGTTtcc and TatAACgt-
GTTctA), one quite similar and the other identical to the 
KstR binding consensus, in a similar way to the cyp450 
pP1/pP2 putative promoter (Fig. 2). The arrangement of 
these promoter and regulatory sequences, lying between 
opposite cluster genes, also occurs in the R. ruber kstD1 
region and it is similar to that found in Mycobacterium 
and Rhodococcus jostii RHA1 genomes [48, 56]. On the 
other hand, Shell et  al. have recently described that the 
abundance of leaderless transcripts (that lack a 5′ UTR 
and a Shine-Dalgarno sequence and that begin with 
ATG or GTG) is a major feature of mycobacterial that 
accounts for around one-quarter of the transcripts [57]. 
kstD3 could be a leaderless ORF: there is no evidence of a 
Shine-Dalgarno sequence in its 5′ region and the putative 
promoter is quite near to the ATG initiation codon. 
Moreover, as it will be stated later, the promoter of this 
intergenic region is functional in Rhodococcus but not in 
E. coli, a fact that has also been confirmed in the myco-
bacterial leaderless messenger translation [57].
Promoter cloning and characterization
To go further in the characterization of the promoter 
regions of the R. ruber kstD ORFs, a promoter-test vec-
tor suitable for R. ruber strain Chol-4 was constructed. R. 
ruber is sensitive to apramycin so we chose the expres-
sion of a gene encoding this resistance as a proof of the 
promoter activity.
pNV119 [43], a Nocardian shuttle vector shown to rep-
licate in R. ruber [24], was modified by adding the mcs 
of pSEVA351 that contains a transcriptional termina-
tor in each extreme [41, 42]. The resulting pNVS plas-
mid (see Additional file 4) was used to study the activity 
of the Chol-4 putative promoter regions. The three kstD 
intergenic regions (Fig. 2) plus the first 21 bases of each 
kstD ORF were PCR amplified, transcriptionally fused 
to the apramycin resistance gene obtained from pIJ773 
and cloned into the mcs of pNVS. The recombinant plas-
mids were introduced into R. ruber by electroporation 
and kanamycin resistant clones were selected. R. ruber 
clones, harbouring the plasmids pNVSP1-A, pNVSP2-A 
or pNVSP3-A, were then plated in minimal medium sup-
plemented with either 1.5  mM cholesterol, 1.5  mM AD 
or 10 mM sodium acetate, and in the presence of either 
200  µg/mL kanamycin or 300  µg/mL apramycin. The 
apramycin resistance gene (Amr) without any upstream 
promoter region was cloned in pNVS mcs generating the 
vector pNVSA that was used as a negative control. As a 
second control, a set of pNVSP vectors that contain every 
promoter region but do not carry the apramycin resist-
ance gene was used. Figure  3 shows that only the cells 
harbouring the double system formed by a putative pro-
moter and the apramycin resistance gene were able to 
grow on apramycin and kanamycin while cells harbour-
ing the pNVSA or the pNVSPs vector were only able to 
grow in kanamycin plates. These results unambiguously 
confirm that all the three checked DNA regions contain 
R. ruber promoter sequences functionally active in the 
conditions used. On the other hand, E. coli harbouring 
the plasmids pNVSP1-A or pNVSP2-A were also able 
to grow in apramycin, in contrast with those harbouring 
pNVSP3-A (data not shown). Other actinobacteria pro-
moters (e.g. some of Mycobacterium and Streptomyces 
spp.; [55, 58] are also not functional in E. coli strains; this 
fact could related to the occurrence of leaderless genes 
[57].
Although none of the online programs recognized a 
promoter consensus for the kstD2 ORF, the promoter-less 
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vector pNVS has enabled us to check the promoter activ-
ity of the intergenic regions. The construction of an 
improved version of this plasmid that allows a quantita-
tive analysis of promoter strength is under work.
To define the transcription start sites (TSS) of the 
kstD genes, the transcription start point protocol (ARF-
TSS) indicated in “Methods” section was followed in R. 
ruber cells. We could conclude that the 5′ terminal base 
in kstD1 messenger RNA is a G resulting from the tran-
scription that starts 34  bp upstream the kstD1 initia-
tion codon. Similarly, the transcription start site of the 
kstD2 gene is a C 48  bp upstream the kstD2 initiation 
codon (Figs. 2, 4). However, this approach did not yield 
any result in the case of the kstD3 gene. In order to bet-
ter define the limits of the kstD3 promoter, progressively 
shorter sections of the intergenic region, keeping the first 
21 bases of kstD3 ORF, were PCR amplified and tran-
scriptionally fused to the apramycin resistance gene. As 
it can be seen in Figs. 2 and 3, just a minimum region of 
only 23 pb upstream the ATG of kstD3 ORF (pNVSP3b-
A vector) was enough to act as a promoter as the Rho-
dococcus cells harbouring this vector were able to grow 
on medium with either apramycin or kanamycin. This 
promoter region is partially similar to the putative pP3 
and pP5 promoters mentioned before, containing the 
TATAAC sequence similar to the −10 consensus motif 
described for Mycobacterium smegmatis promoters 
(Fig. 1).
Putative −35 and −10 hexamers identification was 
based on the sequence of other actinobacteria promot-
ers. The −10 region motif (TAGTGT) found 40 bases 
upstream the kstD1 initiation codon is similar to the −10 
consensus region described for Mycobacterium tubercu-
losis promoters (T80%A90%Y60%G40%A60%T100%) and identi-
cal to the T101 promoter described by Bashyam et al. in 
the same bacteria [55]. No sequence similar to any −35 
motif was found in the kstD1 region. The absence of −35 
motifs seems to be a characteristic of actinobacterial 
genes [55, 58].
There is a putative −10 sequence (TAGCCT) in the 














Fig. 3 Comparative assessment of R. ruber kstD promoters. Cells of 
R. ruber strain Chol-4 harbouring different recombinant plasmids 
were grown in minimal medium supplemented with either 1.5 mM 
cholesterol (kstD2, kstD3 or kstD3b promoters) or 2 mM AD (kstD1 
promoter) in the presence of either 200 µg/mL kanamycin or 300 µg/
mL apramycin. kstDp: R. ruber cells harbouring pNVSP plasmids 
(kstD promoters cloned in pNVS vector). kstDp- Amr: R. ruber cells 
harbouring pNVSP-A plasmids (apramycin resistance gene fused to 
kstD promoters in pNVSP plasmids). Amr: pNVS vector containing the 
promoter less apramycin resistance gene
Fig. 4 ARF-TSS analysis of kstD transcripts. The translation initiation 
codon ATG, the TSS identified by ARF-TSS and the proposed −10 box 
appear in black. R1, R2 and F3 primers are indicated. A grey bar shows 
the sequence obtained by ARF-TSS from the circularized cDNA and 
the subsequent PCR amplification with R2 and F3
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the T6 promoter of M. tuberculosis (TAGGCT) [55]. 
However, it is a bit far away from the kstD2 TSS. There 
is a repetitive motif TCCG in this region (Fig. 2) that also 
appears in the human Sal box element present in the 3′ 
terminal spacer of rDNA and that constitutes a termina-
tion signal for RNA polymerase I (TCCGCACGGGTC-
GACCAG) [59]. In this kstD2 upstream region we found 
something similar: TCCGAGGTCCGCACCGCCGTC-
CGGCGTCGACGAC, where black-underlined letters 
marked the resemblance between them. Such promoter 
proximal terminators can appear also upstream of the 
transcription start site and in this case, they are described 
to positively affect transcription initiation and to pre-
vent transcriptional interference by reading through of 
polymerases from the spacer that separates each rDNA 
repetition [60–62]. The biological significance of this 
motif in this intergenic kstD2 region should be further 
determined.
Transcriptional analysis of kstD genes in R. ruber strain 
Chol‑4
The transcription of the three kstD genes found in R. 
ruber strain Chol-4 was analysed by RT-PCR of RNA 
samples prepared from cultures grown in either M457 
mineral medium or LB medium supplemented with 
either AD or cholesterol as possible inductors.
Control cultures were grown in either M457 supple-
mented with sodium acetate (2  g/L NaAc) or LB, both 
in the absence of any steroid. Using the specific primer 
pairs designed to search for the transcript of each dif-
ferent ORF (Additional file  2), we could show that all 
the kstD genes are transcribed in all the conditions used 
in our assays (Fig.  5) and that transcription of some of 
them is induced by cholesterol or AD. There are also 
other Rhodococcus metabolic genes reported to show a 
low-level constitutive transcription that can be strongly 
induced under the presence of a determinate substrate. 
For instance, phenol degradation genes in R. erythropolis 
are constitutively transcribed and also highly induced by 
phenol [63].
cDNA templates concentrations were adjusted to the 
same value in RT-PCR experiments, so we can consider 
the differences observed in the thickness of some ampli-
fication bands to be meaningful (Fig. 5). Specific ampli-
fication of kstD1 cDNA was higher in AD induced than 
in non-induced cultures, while amplification of kstD3 
cDNA was higher in cultures induced with cholesterol 
as compared to the other conditions assayed. So we can 
conclude that these two genes, although constitutively 
transcribed, they can also be additionally induced by 
the presence of AD (kstD1) and cholesterol (kstD3). The 
induction of kstD genes by cholesterol or AD has also 
been reported in other microorganisms: a 3.3 expression 
ratio (cholesterol/pyruvate) was reported for one kstD 
in R. jostii RHA1 (ro04532) [64, 65], while other puta-
tive kstD genes of the same strain (e.g. ro02483, ro05798 
and ro05813) were up-regulated in 7-ketocholesterol but 
not in cholesterol [64]; the main kstD in M. smegmatis 
(MSMEG_5941) was 13-fold up-regulated in cholesterol 
respect to glycerol [12]; a 1.8, 4.1 or 1.2 -fold up-regula-
tion (AD/glycerol) was found for kstD1, kstD3 and kstD2 
genes respectively in Mycobacterium neoaurum [66]. 
These differences in regulation among the different kstD 
genes within the same strain highlight the view that KstD 
proteins may be acting in different metabolic steps and/
or pathways, each one having a particular catalytic role.
The amplification of R. ruber strain Chol-4 kstD2 
cDNA yielded thick amplification bands in all cases 
Fig. 5 a Analysis of transcription products of kstD genes in R. ruber 
strain Chol-4 by specific RT-PCR amplification and agarose gel elec-
trophoresis. RNA samples were isolated from cultures grown in: M457 
minimal medium supplemented with sodium acetate (lane NaAc), AD 
(lane AD) or cholesterol (lane CHO) and LB medium supplemented 
with (lane LB + AD) or without AD (lane LB). RT—refers to negative 
controls (not incubated with retrotranscriptase) to exclude DNA 
contamination in RNA samples. Primers used in each PCR reaction 
and amplified fragment size are shown in brackets. As non-induced 
expression controls, the transcription of two R. ruber Chol-4 enzyme 
genes was followed in the same conditions: ORF4, that codes for a 
FAD-binding dehydrogenase D092_14375 (99% identity with the 
protein NCIB::WP_010594120.1 of Rhodococcus sp. P14) and ORF5 
(D092_13875) that codes for a fumarate reductase (99% identity with 
NCIB::WP_010594021.1 of Rhodococcus sp. P14; see sequence in Addi-
tional file 6). the FAD-binding dehydrogenase D092_14375 and the 
fumarate reductase D092_13875. b RT-PCR assays of R. ruber Chol-4 
kstD1 and kstD3 transcription carried out in kstD2 R. ruber mutant 
growing in: LB (lane LB) or M457 plus CHO (lane CHO), NaAc and AD 
(lane NaAc + AD) or NaAc (lane NaAc). Lane DNA shows the result of 
the control experiment: PCR made on R. ruber DNA
Page 10 of 16Guevara et al. Microb Cell Fact  (2017) 16:42 
(Fig.  5), which clearly leads to propose a constitutive 
expression of kstD2. In a similar way, two putative kstD 
genes in R. jostii RHA1 genome (ro90203 and ro09040, 
belonging to the KstD2-branch of the KstD phylogenetic 
tree) [20] were expressed but not up-regulated neither in 
cholesterol nor in 7-ketocholesterol, when compared to 
pyruvate [64].
The expression profile of R. ruber kstD1, kstD2 and 
kstD3 genes was determined by real-time PCR. Taking 
as 1 the expression levels on sodium acetate (unexposed 
steroid culture), the values obtained for the expression 
of the three genes were: 7.6, 2.0 and 240.5-fold for kstD1, 
kstD2 and kstD3, respectively, in cultures grown in cho-
lesterol; and 13.6, 0.7 and 0.6-fold for kstD1, kstD2 and 
kstD3, respectively, in cultures grown in AD.
The particular organization of R. ruber Chol-4 kstD1 
and kstD3 genes (Fig. 1) opens the possibility that poly-
cistronic kstD mRNAs could be synthesized by the co-
transcription of the cyp450-kstD1-MFS transporter and 
kstD3-hsd4B-choG gene clusters. The results of the RT-
PCR experiments did not show the occurrence in AD 
culture medium of either cyp450-kstD1 or kstD1-MFS 
transporter RNA sequences, indicating that kstD1 gene is 
independently transcribed.
In contrast, co-transcripts from both kstD3-hsd4B 
ORFs and hsd4B-choG ORFs could be amplified from 
cultures grown in the presence of cholesterol, strongly 
suggesting that kstD3-hsd4B-choG ORFs are co-tran-
scribed into a polycistronic mRNA (Fig. 1). This group of 
three genes are also described to be co-transcribed in R. 
erythropolis [27].
The adjacent location of kstD3-hsd4B ORFs is highly 
conserved among rhodococci. The hsd4B ORF encodes 
a 2-enoyl acyl-CoA hydratase involved in the β-oxidative 
cycle of the C-17 cholesterol side chain [65]. The choG 
ORF encodes an extracellular cholesterol oxidase that it 
is involved in the first step of cholesterol catabolism that 
implies its conversion to 4-cholesten-3-one [27, 47, 67–
69]. All this suggests that kstD3, hsd4B and choG genes 
are mainly involved in the steroid catabolism.
In this work we showed that kstD2 is constitutively 
transcribed, while kstD1 and kstD3 are also constitu-
tively but faintly transcribed, although they can be highly 
induced by AD or CHO. In a previous work [24], we 
reported the construction of a kstD2 deletion mutant of 
R. ruber that is unable to grow in minimal medium sup-
plemented with AD. The question is why KstD1 and/
or KstD3 cannot substitute KstD2 allowing the kstD2 
deletion mutant to grow on AD. To partially advance in 
this subject, RT-PCR experiments were also performed 
on RNA from the kstD2 R. ruber mutant to check the 
expression of the other kstD genes (Fig. 5b).
The results showed that the transcription pattern of 
the kstD genes of the mutant is far different than that of 
the same genes in the wild type. Namely, kstD1 gene in 
the mutant was constitutively and slightly transcribed 
and its expression is induced in CHO. A more noticeable 
change affects to the kstD3 gene, which is not transcribed 
at all in any of the conditions used. These data reveal a 
complex relationship among the KstD enzymes and their 
expression control mechanisms. Modification of the 
kstD transcription levels of genes remaining in the cell 
have also been described in a M. neoaurum kstD mutant: 
the transcription ratio of the kstD1 ORF (similar to the 
kstD3 ORF from R. ruber) in AD induced cultures respect 
to glycerol cultures increases from 1.8 (in the wild type 
strain) to 2.7-fold (in the kstD3  M. neoaurum mutant 
strain) [66].
An appealing conclusion of that complex situation is 
that the three KstD proteins of R. ruber strain Chol-4 
may be differentially involved in distinct pathways of 
steroid degradation, and that their expression could also 
be differentially and specifically controlled.
Heterologous expression of KstD1, KstD2 and KstD3 of R. 
ruber strain Chol‑4
The three R. ruber kstD genes (kstD1, kstD2 and kstD3) 
were cloned into the pTip-QC1 expression vector. R. 
erythropolis CECT3014 cells were electroporated with 
these constructions and clones harbouring each of those 
recombinant plasmids were isolated. Expression of the 
KstD proteins from these vectors in the CECT3014 trans-
formed cells was followed by SDS-PAGE analysis. Molec-
ular weights were 54.8, 60.8 and 61.8  kDa for KstD1, 
KstD2 and KstD3 respectively (Additional file  5). Cell-
free extracts of cultures grown from these clones were 
used for the analysis of KstDs activities, and the kinetic 
parameters of the heterologously expressed KstDs from 
R. ruber were followed for different substrates (Table  1; 
see also Additional file 3 for substrates structure). Con-
trol cell extract from the R. erythropolis culture harbour-
ing an empty pTip-QC1 vector yielded none or very low 
basal levels when acting on all the substrates used in the 
assay and were taken into account for final activities.
The substrate profile of KstD1 showed a clear prefer-
ence to 9OHAD and testosterone, followed by proges-
terone, Deoxy corticosterone (DOC) and AD (Table  1). 
All these compounds display a keto group at C3, a 
C4-C5 double bond and an electronegative side-chain 
at C17 (Additional file  3). When comparing to the sub-
strate preference order of R. erythropolis SQ1 KstD1 
(Prog > 9OHAD, AD > 5α-Tes > BNC > 11βCort), some 
details highlights: (i) KstD1SQ1 has a relative catalytic effi-
ciency (RCE) on progesterone 3.4 times higher than on 
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AD, a very big difference to the ratio 9OHAD/AD (1.6) 
showed by R. ruber KstD1 (Table 1); (ii) R. ruber KstD1 is 
not active on 5α-Tes in contrast to KstD1SQ1.
The order of substrate preference of R. ruber KstD2 
placed progesterone in the first position, followed by 
5α-Tes, DOC, AD and testosterone (Table  1), display-
ing a substrate profile similar to KstD2SQ1 enzyme 
(Prog  >  AD  >  5α-Tes  >  9OHAD, BNC  >  11βCort). It is 
noteworthy the similarity of both KstD profiles, having in 
mind that they have been expressed in different cellular 
context (a Rhodococcus strain, and E. coli). R. ruber KstD2 
has a broader range of substrates than R. ruber KstD1 as 
it can act on all the KstD1 substrates and also on 5α-Tes 
that contains a saturated A ring (Table 1).
Rhodococcus ruber KstD3 did not show any activity at 
all when acting on AD or 9OHAD, which are considered 
the natural substrates for KstD enzymes, but it showed 
the highest activity when using 5α-Tes as substrate fol-
lowed by progesterone and lastly DOC (Table 1). R. ruber 
KstD3 has a very narrow substrate range similarly to the 
R. erythropolis SQ1 and M. tuberculosis H37Rv isoforms, 
being the A-ring saturated 5α-Tes the preferred substrate 
for all KstD3 enzymes (Table  1, [20]). However, KstD3 
affinity for 5α-Tes differs from 33–36  µM in the cases 
of KstD3H37RV and KstD3SQ1 respectively, to 181  µM 
in R. ruber KstD3 (Table 1). Despite this low affinity for 
5α-Tes, this is the best substrate for the R. ruber enzyme 
among those that were assayed (Table 1).
On the other hand, although it has been proposed that 
only steroids carrying a small or no aliphatic side chain 
at C-17 are suitable substrates for KstD3 [20], a minor 
activity, not very different to that obtained with proges-
terone, has been observed in the assays of R. ruber KstD3 
enzyme on DOC (Additional file  3; Table  1). R. ruber 
KstD3 seems to be more related to the cholesterol metab-
olism than to the AD metabolism [24] and then it could 
be acting on some not yet neatly defined intermediaries 
of the bacterial cholesterol metabolism.
None of the three R. ruber KstD proteins displayed 
detectable activity on 4-cholestene-3-one, 5α-cholestane-
3-one or 5β-androstane-3,17-dione (5β-AD), ADD, 
cholesterol, cholestenone, cholic acid, DHEA, ergos-
terol, stigmasterol, β-estradiol, sodium deoxycholate or 
5-pregen-3-β-nolone. Therefore, these KstDs catalyse 
preferentially 4-ene-3-oxosteroids.
Molecular modelling of KstD1 of R. ruber strain Chol‑4
The sequence of the three KstDs of R. ruber were 
described previously [24]. In an attempt to go deeper 
inside the reasons of the catalytic and kinetic differ-
ences among some of these enzymes, we performed pro-
tein sequence analysis and modelling studies on the R. 
ruber KstDs using different approaches. The published 
three-dimensional structure and the catalytic mechanism 
proposed for KstD1 from R. erythropolis SQ1 has been 
used as a suitable model [21, 70]. The I-Tasser and Pre-
dictProtein programmes predicted that none of the three 
R. ruber KstDs contain sulphur bridges or transmem-
brane segments.
The catalytic mechanism of R. erythropolis SQ1 KstD1 
is based in the keto-enol tautomerization of the substrate 
caused by Tyr487 and Gly491 residues that increases the 
acidity of the C2 hydrogen atoms of the substrate. Then 
Tyr119 and Tyr318 capture the axial β-hydrogen from 
C2 as a proton whereas the FAD molecule accepts the 
axial α-hydrogen from the C1 atom of the substrate as 
a hydride ion [21, 70]. Tables  2 and 3 collects the resi-
dues involved in the active site of KstD1SQ1 described 
for Rohman et  al. [21] and the homologue residues 
of the three KstDs from R. ruber found by COBALT 
Table 2 Homologous residues of  KstDs implicated in  the 
catalytic pocket attending to Rohman et al. [21]
Italic files contain the four key residues of the KstD1 active site reported for R. 
erythropolis SQ1: Tyr119, Tyr318, Tyr487 and Gly491
KstD1‑SQ1 KstD1‑ruber KstD2‑ruber KstD3‑ruber
S52 G53 A59 G50
F116 W118 Y125 Y116
Y119 Y121 Y128 Y119
F294 F295 P337 F327
V296 L297 V339 S330
Y318 Y319 Y366 Y354
I352 T356 I395
I354 V358 F405 P397
L447 L447 L499 L490
Y487 Y487 Y539 Y530
P490 G490 A542 P533
G491 G491 G543 G534
V492 N492 A544 A535
P493 P493 T545 T537
Table 3 PredictProtein prediction of  the secondary struc-
ture and  solvent accessibility in  % of  the three KstDs 
from R. ruber
Structure KstD1 KstD2 KstD3
Strand 12.72 11.88 64.74
Loop 63.99 64.01 14.38
Helix 23.29 24.11 20.88
Accessibility KstD1 KstD2 KstD3
Exposed 24.1 21.81 22.11
Buried 67.7 71.63 70.5
Intermediate 8.22 6.56 7.54
Page 13 of 16Guevara et al. Microb Cell Fact  (2017) 16:42 
programme. The four key residues: Tyr119, Tyr318, 
Tyr487 and Gly491 of the KstD1SQ1 active site have a 
counterpart residue in the R. ruber KstDs. However, the 
I-TASSER model prediction of these R. ruber enzymes 
shows that the orientations of the side chain of the tyros-
ine residues differ within the catalytic pocket site being 
specific of each enzyme. The variation in orientation of 
the key residues inside the catalytic poked is shown in 
Fig.  6. Particularly, the orientation of KstD3 Y354 and 
Y530 residues is almost opposite to that of its homolo-
gous KstD1 and KstD2 residues. Moreover, amino acid 
Y128 from KstD2 has a position highly separated com-
pared to its homologous from KstD1 (Y121) and KstD3 
(Y119). These differences could justify the different affin-
ity and catalytic properties among the three KstDs. The 
current shortage of crystalline structures of these pro-
teins greatly limit more detailed conclusions.
A redundancy of KstD and Ksh enzymes have been 
described in the actinobacteria genomes [20, 24, 64, 70]. 
This redundancy could provide the cell with a bigger met-
abolic versatility and a fine-tuned response to the chal-
lenging environment. In the case of KstD enzymes, three 
homologues have been found in R. erythropolis strain SQ1 
and in M. neoaurum that displayed different substrate 
preferences and that could be involved in different meta-
bolic steps in a strain-dependent way [20, 32, 66].
Even more, it has been shown recently that mutations 
in the KstDs provokes a different ADD/AD molar ratio 
[71] and that environmental factors such as an increase 
of temperature can inhibit the KstD/Ksh action [72] on 
phytosterol in Mycobacterium sp. These multiplicity and 
versatility give to these enzymes a substantial role in the 
catalytic dehydrogenation of several related steroid mol-
ecules and pose many difficulties to clarify the particular 
role and way of acting of every single KstD.
Our results suggest that both KstD1 and KstD2 of R. 
ruber could act in the conversion of AD to ADD being 
KstD1 mainly involved in the 9OHAD to 9OHADD con-
version, in a similar way to what has been described in 
R. erythropolis SQ1 [32]. However, there are differences 
between these two strains, as the necessity of a double 
kstD1 and kstD2 mutation to prevent the growth in AD 
in the case of R. erythropolis SQ1 [32] or R. rhodochrous 
DSM43269 [73], while the same effect is obtained by the 
single kstD2 deletion in R. ruber strain Chol-4 [24], sug-
gesting that this last mutation affects in some way the 
activity of the KstD1 protein.
kstD3 ORF occurs in the R. ruber genome in a quite 
conserved location within Rhodococcus species, clustered 
with hsd4B (which encodes a 2-enoyl acyl-CoA hydratase 
proposed to be involved in cholesterol side-chain short-
ening) [65] and choG (coding for a cholesterol oxidase 
that converts cholesterol into cholestenone) [27, 47, 68]. 
Recently it has been proposed that sterols can be catab-
olised in R. equi USA-18 by two partially different path-
ways, namely via AD or via Δ1,4-BNC, that converge in 
the intermediary 9OHADD [74]. Given its substrate pref-
erence, the fact that the growth in AD is independent of 
the KstD3 activity while the growth in cholesterol needs 
the presence of either KstD2 or KstD3 in R. ruber [24], 
lead us to suggest that KstD3 may be involved in an alter-
native AD-independent cholesterol catabolic pathway.
Conclusions
To sum up, this study provides biochemical and genetic 
insights into the three KstD proteins found in R. ruber. 
The kinetic differences between the three KstDs sug-
gest that each enzyme could act on different steps of the 
steroid catabolic routes. Both KstD1 and KstD2 could be 
involved in the AD catabolism while KstD1 would have 
a preference for 9OHAD and KstD2 for progesterone. 
KstD2 seems to be a more versatile enzyme than KstD1 
in R. ruber as it can act also on saturated steroid sub-
strates such as 5α-Tes. On the other hand, the narrower 
range of substrates for KstD3 and its preference for satu-
rated steroid made this enzyme different to KstD1 and 
KstD2 and suggest that it may be involved in AD-inde-
pendent steroid catabolism. The differences found in the 
orientation of catalytic residues of each KstD within the 
binding pocket site could explain the substrates prefer-
ences of each enzyme.
The promoter regions that support transcription of 
kstD genes have been cloned and functionally identified. 
The three promoter boxes contain different expression 
patterns, from the TCCG motif found in the kshA-kstD2 
ORF intergenic region to the KstR boxes in the hsaE-
kstD3 intergenic region. Moreover, kstD3 ORF was tran-
scribed as a polycistronic kstD3-hsd4B-choG mRNA and 
Fig. 6 Modelling of the active site of KstDs. The orientation of the 
four key residues in the KstD binding pocket is shown. They are 
superposed and depicted in different colours: green for KstD1, blue 
for KstD2 and red for KstD3. Only KsD1 residues are named, their 
counterpart homologues residues of KstD2 and KstD3 being listed in 
Tables 2 and 3
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was induced in cholesterol growing media, reinforcing 
the role of KstD3 in the cholesterol metabolism. Potential 
functions of R. ruber strain Chol-4 KstDs in other steroid 
pathways remain to be elucidated.
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